Connor, Clark & Lunn Investment Management (CC&L)
SYNH

Connor, Clark & Lunn Investment Management (CC&L)’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-167,282
Closed -$5.96M – 1561
2023
Q1 		$5.96M Sell
167,282
-213,194
-56% -$7.74M 0.03% 334
2022
Q4 		$14M Buy
380,476
+372,554
+4,703% +$14.7M 0.08% 186
2022
Q3 		$374K Sell
7,922
-1,579
-17% -$102K ﹤0.01% 876
2022
Q2 		$681K Buy
+9,501
New +$695K ﹤0.01% 703
2017
Q4 		– Sell
-70,119
Closed -$3.67M – 875
2017
Q3 		$3.67M Buy
+70,119
New +$3.91M 0.02% 338

Other funds holding SYNH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s SYNH Position: Q2 2023 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2023, closing a stake of 167,282 shares — an estimated $5.96M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in SYNH in Q3 2017 and held it in 5 quarters. The position peaked at $14M in Q4 2022. 317 funds tracked by Wall St. Rank hold SYNH as of Q2 2023.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 167,282 Syneos Health, Inc. Class A Common Stock shares in Q2 2023, an estimated $5.96M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2017 and held it in 5 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Syneos Health, Inc. Class A Common Stock position peaked at $14M in Q4 2022.
  • 317 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2023.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2023, filed 10 Aug 2023.